Thus, complete early reversal of DWI hyperintensities is possible, but frequency, associated characteristics, and clinical significance remain unknown. The aim of this study was to Background and Purpose-Case reports have demonstrated complete early reversal of hyperintensities on diffusion-weighted imaging (DWI) after clinically diagnosed stroke. We aimed to investigate systematically the rate and characteristics of reversible diffusion hyperintensities (RDHs) in the first week after stroke. Methods-Patients with clinical diagnosis of an acute cerebrovascular event and evidence of ischemia on DWI were included.
D iffusion-weighted MR imaging (DWI) is the most sensitive technique currently used in the early diagnosis of acute ischemic stroke. 1 Usually, DWI signal hyperintensities corresponding to ischemic areas occur within minutes after onset of symptoms 2 and remain hyperintense within the first weeks after stroke. 3, 4 The signal increase most likely results from a decrease in Brownian molecular motion caused by a translation of water molecules from the extracellular into the intracellular space. This has been widely regarded to indicate irreversible tissue damage, although animal research and positron emission tomography studies suggest the possibility of tissue recovery within DWI hyperintensities. 5, 6 In recent years, the extent of DWI lesion reversal has been a matter of debate. A metaanalysis found partial DWI lesion reversal in a quarter of patients within the first few days after stroke. 7 Another more recent study showed sustained lesion size reduction in only 7% of the patients on follow-up fluidattenuated inversion recovery (FLAIR) or T2 images after exclusion of gliosis and cerebrospinal fluid. 8 Animal studies have reported complete early reversal of DWI hyperintensities after short hypoperfusion periods, but reversal was often temporary and did not necessarily indicate full tissue recovery as shown by histopathology. 9, 10 Single case reports have also demonstrated complete reversal of DWI hyperintensities within the first 24 hours in humans.
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investigate the rate and characteristics of reversible DWI hyperintensities (RDHs) in the first week after ischemic stroke.
Methods Patients
Patients with the clinical diagnosis of an acute cerebrovascular event who were admitted to our stroke center between March 2008 and July 2009 and who were eligible for MRI were included. Followup scans were performed in patients with an MRI diagnosis of acute infarction at the first measurement; participating patients provided written informed consent. All patients received standard stroke unit care. Patients undergoing any surgical intervention, carotid artery stenting, or intra-arterial thrombolysis were excluded. The study was performed as a substudy of the ongoing 1000+ study, which has been registered at clinicaltrials.gov NCT00715533 and was approved by the local Ethics Committee of the Charité (EA4/026/08).
MR Imaging
All examinations were performed with a 3 Tesla MR scanner (Tim Trio, Siemens AG, Erlangen, Germany). In the 1000+ study, MR examinations are scheduled at 3 time points: on admission, on the following day, and on day 4 to 7 after onset of symptoms. Sequences included high-resolution DWI (slice thickness 2.5 mm without gap, field of view 23×23 cm, acquisition matrix 192×192, TR/TE 7600/93 ms, imaging time 2 minutes 11 seconds), FLAIR (slice thickness 5 mm with a 0.5 mm gap, field of view 22×22 cm, acquisition matrix 256×232, TR/TE/TI 8000/100/2370 ms, imaging time 1 minute 54 seconds), as well as T2*, time-of-flight MR angiography, and perfusion imaging. Diffusion measurements with one B0 and along 6 directions at b=1000 s/mm² were also used to calculate maps of the apparent diffusion coefficient (ADC). DWI and FLAIR had to be available for all 3 time points to be included for final analysis in this study.
MRI Assessment
DWIs were anonymized and reviewed in random order by raters (F.N.A., J.B.F., K.V.) blinded to clinical information. Hyperintensities on randomized DWI were delineated manually. Signal increase solely attributable to T2 shine-through was ruled out by comparison with FLAIR and ADC maps. DWI, FLAIR, and ADC maps were then coregistered and resliced to 1-mm isotropic voxel size. The number of initial DWI hyperintensities at the first measurement was assessed for all patients. The presence of >1 initial hyperintensity was described as a multiple hyperintensities pattern. Grouped adjacent lesions and hyperintensities that were confluent on later images were counted as a single hyperintensity. Coregistered DWIs were analyzed visually for RDHs as well as for new hyperintensities through slice-by-slice comparison using the previously delineated regions of interest.
14 Clearly visible initial hyperintensities that were no longer visible on the second or third DWI were considered to be a RDH. New lesions on the second or third DWI were detected regardless of size and ADC value in this study.
Total initial DWI lesion volume and the sizes of individual hyperintensities were calculated using regions of interest of the first measurement. Because mean ADC values of small lesions are subject to partial volume effects and high interobserver variability, we chose to assess minimum initial ADC values for all hyperintensities. Cortical location was assessed for all initial lesions. Cerebellar cortex was not considered for cortical location because it is not easily distinguishable using DWI. Furthermore, we examined whether RDHs or persistent hyperintensities had any corresponding signal increase on coregistered FLAIR images at the third measurement. In cases of preexistent FLAIR abnormalities (eg, extensive white matter changes), this information could not be obtained. Careful windowing was performed to detect subtle FLAIR abnormalities. When in doubt, a corresponding abnormality was assumed.
Clinical Data
Sociodemographic and laboratory data as well as previous prophylactic therapy (statins, oral anticoagulation, antiplatelet therapy including acetylsalicylic acid, clopidogrel, or acetylsalicylic acid combined with dipyridamole) were collected from the medical records. Etiology was assessed according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification of stroke subtype. 15 All patients were assessed for stroke severity directly before the first MRI examination and daily until the day of discharge by physicians certified to assess the National Institutes of Health Stroke Scale (NIHSS) score. 16 Early functional improvement was defined as a NIHSS change to zero or an improvement of >3 points 17 between patient admission and discharge. Symptomatic carotid stenosis was defined as stenosis >50% on color-coded duplex sonography or MR angiography with ipsilateral infarction. MR angiography was also used to determine significant recanalization and any intracranial stenosis or occlusion. In 3 patients (2%), follow-up MR images were completely normalized. In 37 patients (24%), ≥1 DWI hyperintensity reversed within the first 7 days after stroke ( Figure 1 ). Of 611 separate initial hyperintensities, 97 (16%) reversed on DWI. Twenty-three (4%) hyperintensities reversed between the first and second examination and 74 (12%) between the second and third examination. None of the hyperintensities with early reversal reappeared on the third DWI.
Data Analysis
RDHs were significantly smaller than the persistent hyperintensities. The largest RDH had a size of 0.981 mL. RDHs also had a less severe initial ADC decrease, and they were more often restricted to cortex ( (Table 2 ). Patients with RDHs had a higher rate of new additional hyperintensities within the first week in univariate analysis ( Figure 2 ). The occurrence of RDHs was not associated with functional improvement on the NIHSS between admission and discharge. In stepwise backwards multivariate logistic regression analysis, a pattern of multiple initial hyperintensities (odds ratio, 22.12; 95% confidence interval, 4.46-109.69; P<0.001) and symptomatic carotid stenosis (odds ratio, 5.53; 95% confidence interval, 1.42-21.53; P=0.014) were independently associated with RDHs.
Discussion
For the first time, we have systematically described incidence and characteristics of individual DWI hyperintensities that reverse completely within a few days after symptom onset. Previous studies focused on larger lesions and reported their persistence up to a few weeks. 3, 4 Several studies have shown partial early size reduction of large DWI lesions, 7 ,8 yet complete early reversal of DWI hyperintensities in humans has so far only been reported in selected cases. [11] [12] [13] In this population of patients with mainly small infarcts of minor to moderate severity, a complete normalization of MR images was seen in 2% of the patients. Individual RDHs occurred in 24% of the patients, and 16% of all initial hyperintensities reversed completely on DWI.
RDHs were very small and had a less severe initial ADC decrease than the persistent lesions did. These characteristics may mirror less severe initial hypoperfusion and cell edema, which could have facilitated early recovery. 18, 19 However, some of the RDHs had persistent signal abnormalities on follow-up FLAIR at the third measurement. In these cases, a shortened natural evolution of the DWI signal increase without any tissue recovery can be assumed. Of all initial DWI lesions, 13% could be established as normal on follow-up DWI as well as FLAIR. This rate is likely to be overestimated, because FLAIR had a higher slice thickness than DWI and an interslice gap in our study. Given the small size of the lesions, a number The RDHs observed in our study are only partly characterized by small sizes and less severe ADC decreases. Hyperintensities of small-vessel etiology (lacunar lesions) are also small, but they reversed significantly less often. In contrast, complete reversal was more frequent among cortical hyperintensities and in patients with symptomatic carotid stenosis and multiple initial hyperintensities. Many patients with RDHs also had new clinically silent lesions within the first week ( Figure  2) . These results indicate a strong association of RDHs with embolic stroke and suggest a pattern of recurrent embolism over time. Not all lesions seen at baseline necessarily date from symptoms that led to admission in these patients. The presence of older lesions may explain why some DWI lesions reversed before others as a result of the natural history of DWI evolution. Because some of the RDHs were clearly new (Figure 1 ), this explanation does not account for all reversible lesions, but it is a likely reason for reversal in many cases, especially when persistent FLAIR abnormalities were seen. In addition, ischemic preconditioning attributable to earlier lesions could have contributed to lesion reversal. 21 Our results are in line with transcranial Doppler studies, which have shown high rates of microembolic signals in the acute phase after transient ischemic attack and stroke, especially in patients with symptomatic carotid stenosis. 22, 23 Other transient ischemic attack and minor stroke studies have also demonstrated high rates of early clinical recurrence in these patients. 24 ,25 
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A recent study with larger infarcts in more severely affected patients concluded that clinically relevant DWI lesion size reduction was uncommon on follow-up FLAIR and T2 imaging. 8 Our results support the notion that complete early reversal of large lesions is rare. RDHs did not predict a significantly higher percentage of patients with functional improvement in our study. Furthermore, there was a very low number of patients with a complete normalization of MR images. Very early lesion reversal before the first MRI may have been missed in some cases. Early lesion size reduction is more commonly observed when the first MRI is performed shortly after symptom onset, 19 yet time difference between groups did not reach statistical significance in our study.
This study has limitations. The generalizability of our results is limited by the monocentric design. The requirement of informed consent and 3 consecutive scans limited the patient selection mainly to small infarcts of minor to moderate clinical severity. The reliability of the multivariate regression analysis is hampered by the sample size and the small number of patients with RDHs. The sample size might have been too small to detect possible differences between groups in univariate analysis (type II error). Considering the small size of the RDHs, incidence and lesion characteristics are subject to inter-and intraobserver bias, but general trends should not be affected. Artifactual disappearance of hyperintensities on DWI may have caused overestimation of the reported rate of RDHs, yet the complete lack of lesions that resolved at the second measurement and reappeared at the third measurement argues against a significant influence of artifactual reversal. Further studies with a smaller slice thickness of FLAIR images would be needed to allow a more accurate description of RDHs without corresponding FLAIR abnormalities.
In conclusion, complete early normalization of MR images was rare in this population of mainly minor to moderate stroke patients. Complete reversal of individual DWI hyperintensities was less rare. However, RDHs were very small and reversal was not associated with significant functional improvement. RDHs mostly occurred in patients with embolic stroke, and it may represent ongoing recurrent embolism.
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